Background. Breakthrough zygomycosis is increasingly observed among patients at high risk for fungal infection who are receiving voriconazole, reflecting either selective pressure or voriconazole-associated alterations in Zygomycetes virulence. We tested the latter hypothesis, using 2 phylogenetically disparate zygomycosis models.
Invasive fungal infections have emerged as major causes of morbidity and mortality in severely immunocompromised individuals, such as patients with cancer who are undergoing chemotherapy and persons who received a hematopoietic stem cell transplant [1] . Voriconazole, a triazole that has activity against Candida and Aspergillus species, is increasingly used prophylactically in patients at high risk for fungal infections [2] . However, despite its broad spectrum of activity, voriconazole is ineffective against fungi of the class Zygomycetes [3] . In recent studies, investigators have described the emergence of zygomycosis as a breakthrough infection in patients with hematologic malignancies who are receiving voriconazole-based prophylaxis [1, 2, 4 -8] . The increasing incidence of zygomycosis among immunosuppressed patients is a concern because of the extremely high associated mortality rates in this population [1, 9] .
Given the complex and largely unknown pathogenesis of zygomycosis [9] , it is unclear whether the increasing incidence of this infection is due to selective pressure imposed by voriconazole, which creates an ecological vacuum that is filled by Zygomycetes [5] , or is due to subtle changes in the virulence of Zygomycetes organisms that have been exposed to voriconazole. To test the latter hypothesis, we assessed the effect of voriconazole exposure on the virulence of Zygomycetes strains, using 2 disparate animal models of infection. Initially, we used Drosophila melanogaster as a highthroughput minihost model to screen for voriconazoleassociated changes in the virulence of 3 clinical Zygomycetes strains. We then validated our findings for this fly model by use of a corticosteroid-treated murine model. We found that, in both models, preexposure of Zygomycetes strains to voriconazole was associated with significantly reduced rates of host survival. Furthermore, in the murine model of zygomycosis, infection with a voriconazole-exposed Rhizopus oryzae strain was associated with a higher pulmonary fungal burden, more-severe tissue injury, and a more pronounced inflammatory response, compared with infection with a R. oryzae strain that was not exposed to voriconazole. Preexposure of R. oryzae to other antifungal agents and exposure of an Aspergillus fumigatus strain to voriconazole did not affect the virulence of these fungi.
MATERIALS AND METHODS
Fungal isolates and preexposure to drugs. Three clinical Zygomycetes strains (R. oryzae 557969, R. oryzae 518749, and Mucor circinelloides 488128), obtained from patients with invasive zygomycosis at the University of Texas M. D. Anderson Cancer Center, and a reference A. fumigatus strain (A. fumigatus 293) were used. The strains were exposed to voriconazole, itraconazole, caspofungin, or amphotericin B in 4 serial passages on yeast-extract agar glucose (YAG) plates containing subinhibitory concentrations of the drugs (i.e., 4 g/mL of voriconazole, 1 g/mL of itraconazole, 0.25 g/mL of amphotericin B, and 16 g/mL of caspofungin for the Zygomycetes strains and 0.0625 g/mL of voriconazole for A. fumigatus 293) (figure 1) [10] . In each passage, spores were harvested after 48 h of incubation at 37°C, washed with saline, and immediately spread on fresh YAG plates. Susceptibility testing of isolates by broth microdilution after each passage did not show a change in the minimum inhibitory concentration of voriconazole (data not shown). The same strains were serially passaged 4 times on drug-free YAG plates and used as controls. To assess phenotype stability, voriconazole-exposed R. oryzae 557969 was serially passaged 4 times on drug-free YAG plates. D. melanogaster model of zygomycosis. Oregon R flies were used as wild-type (WT) organisms. Toll transheterozygotes (i.e., Tl Ϫ/Ϫ flies) were generated by crossing flies carrying a thermosensitive allele of Toll (Tl r632 ) with flies carrying a null allele of Toll (Tl l-RXA ) [11, 12] . Female WT and Tl Ϫ/Ϫ flies aged 2-4 days were used; there were 30 flies per experimental group. Infection was performed by inserting a thin needle previously dipped in a Figure 1 . Diagram of experiments performed to assess the effect of voriconazole exposure on the virulence of Zygomycetes isolates. The isolates Rhizopus oryzae 557969, R. oryzae 518748, Mucor circinelloides 488128, and Aspergillus fumigatus 293 were serially passaged on yeast-extract agar glucose (YAG) plates that were or were not supplemented with 4 g/mL voriconazole (VRC). Spores collected following the last serial passage were used to inoculate wild-type (WT) or Toll-deficient (Tl Ϫ/Ϫ ) flies or cortisone acetate-suppressed BALB/c mice. Survival curves for the animals infected with voriconazole-exposed and nonexposed isolates were compared. Mouse lungs were further studied by use of quantitative polymerase chain reaction (qPCR), to determine the fungal burden; by histopathological analysis; and by microarray analysis, to determine expression of inflammation-associated genes.
suspension of spores (concentration, 10 6 cells/mL [counted using a hemacytometer]) into the thorax of each fly (figure 1) [13] . To quantify the spore inoculum, a needle was dipped in the spore suspension as described above, and the inoculum was diluted in 1 mL of 0.85% normal saline. Quantitative cultures were performed by plating serial dilutions of the resulting suspensions on YAG plates and counting the colony-forming units after 72 h of incubation at 37°C. A suspension of 10 6 spores/mL resulted in an inoculum of ϳ2 ϫ 10 2 spores/fly for the R. oryzae and M. circinelloides strains and ϳ5 ϫ 10 2 conidia/fly for A. fumigatus 293 [11, 13] . Following infection, flies were kept at 29°C and were transferred to fresh vials every 2 days. Flies that died 3 h after infection were excluded from the survival analysis. Survival was assessed until day 8 after infection. All experiments were performed on 3 different days at the same time of day, to eliminate circadian rhythm-associated variability.
Murine model of zygomycosis. We used female BALB/c mice (Harlan Sprague Dawley) weighing ϳ25 g each. The mice were housed in presterilized, filter-topped cages at a density of 5 animals/cage and received sterile food, water, and bedding in a biohazard isolation suite. All procedures were performed according to the highest standards for humane handling, care, and treatment of research animals and were approved by the M. D. Anderson Cancer Center and the University of Houston Institutional Animal Care and Use Committees.
All murine experiments were performed 3 times, each on a different day. Mice were immunosuppressed via subcutaneous injection of 4 doses of cortisone acetate (Sigma) at 250 mg/kg in 100 L of a sterile saline solution on days 4 and 1 before infection and on days 2 and 5 after infection, as described previously [14] . In each of 3 experiments, 4 groups of 10 mice were infected via intranasal instillation of a 35-L droplet of a spore suspension of R. oryzae 557969, as follows: (1) voriconazole-exposed R. oryzae 557969, high inoculum (10 6 spores/mL; ϳ35 ϫ 10 3 spores/ mouse); (2) voriconazole-exposed R. oryzae 557969, low inoculum (5 ϫ 10 4 spores/mL; ϳ1.75 ϫ 10 3 spores/mouse); (3) voriconazole-nonexposed R. oryzae 557969, high inoculum; and (4) voriconazole-nonexposed R. oryzae 557969, low inoculum (figure 1). The spore viability was Ͼ99%, as determined using quantitative plating of serial dilutions taken from the original inocula.
The animals were observed daily, and survival was assessed during the 10-day period after infection. Animals that appeared to be moribund were euthanized by CO 2 asphyxiation, and death was recorded as occurring 12 h later. On day 10 after infection, all surviving mice were euthanized.
Fungal burden quantification using real-time quantitative polymerase chain reaction (qPCR). In 2 of the 3 murine experiments (total, 80 mice), lungs were removed after euthanization and stored at Ϫ80°C until qPCR analysis of the fungal burden. DNA was extracted from lung homogenates, using the DNeasy tissue kit (Qiagen), and DNA samples were analyzed in duplicate, using the ABI PRISM 7000 sequence detection system (Applied Biosystems). Primers and dual-labeled fluorescent hybridization probes specific for R. oryzae 18S ribosomal RNA were designed using the ABI PRISM SeqScape software program (version 2; Applied Biosystems). The sequence of the oligonucleotides were as follows: (1) sense amplification primer, 5'-AGGGCTTTGCTGCACGAC-3'; (2) antisense amplification primer, 5'-TCCACCTCGGGACTGTTTG-3'; and (3) hybridization probe, 5'-FAM-TGCTACTGTTGCAGACCGCCGCT-TA-MRA-3' [14, 15] . The threshold cycle (C t ) of each sample was interpolated from a 6-point standard curve of C t values prepared by spiking uninfected mouse lungs with 10 2 -10 7 R. oryzae spores. The PCR results were reported as spore equivalents of R. oryzae DNA.
Histopathological analysis. Whole-lung tissue samples were obtained from euthanized mice in each of the 4 infection groups every 24 h, starting 72 h after infection. The samples were fixed in 10% formaldehyde, processed, and embedded in paraffin. Tissue sections were stained with hematoxylin-eosin, Grocott-Gomori methenamine-silver nitrate, and cresyl violet and examined under a light microscope.
Inflammation-associated gene expression in mouse lungs. The expression of 1076 inflammation-associated genes was analyzed in the lungs of mice infected with R. oryzae 557969 that was preexposed to voriconazole, mice infected with voriconazolenonexposed R. oryzae 557969, and uninfected control mice (3 mice/ group). RNA was extracted from mouse lungs by use of the RNeasy kit (Qiagen) and analyzed using an Agilent 2100 bioanalyzer with the 2100 Expert software program (Agilent Technologies). The RNA quality was determined by visual inspection of electropherograms and the RNA integrity number generated by the software program. cDNA templates were synthesized using the MACS 1-step linear T7 template kit (Miltenyi Biotec). cDNA from control and experimental samples was labeled with Cy3 and Cy5, respectively, using the MACS 1-step labeling kit (Miltenyi Biotec). The control samples were pooled for the labeling procedure. Fluorescent-labeled samples were hybridized overnight to PIQOR immunology mouse antisense microarrays, using the a-Hyb hybridization station (Miltenyi Biotec). Fluorescence signals in the hybridized microarrays were detected using a ScanArray Lite laser scanner (PerkinElmer Life and Analytical Sciences). The mean signal intensity of each spot was calculated using the ImaGene software program (BioDiscovery). Low-quality spots were flagged and excluded from the analysis. The PIQOR analyzer software program was used for analysis, normalization, and calculation of Cy5:Cy3 ratios on the basis of unflagged spots.
Statistical analysis. Survival curves for the mice and flies following infection were plotted using Kaplan-Meier analysis, and differences in the survival rates between groups were assessed using the log-rank test. The pulmonary fungal burdens (measured in terms of spore equivalents) in the groups of mice were compared using the Mann-Whitney U test. Gene expres-sion in mouse infection groups was compared using the unpaired Student t test. P values were corrected for multiple comparisons, using the Benjamini-Hochberg method. For all comparisons, P values of Ͻ.05 were considered statistically significant.
RESULTS

Exposure of Zygomycetes strains to voriconazole increased their virulence in WT and
Tl ؊/؊ flies. We observed that WT flies were susceptible to infection with the 3 clinical Zygomycetes isolates. Infection of WT flies with the R. oryzae 557969 strain resulted in a survival rate of 61% at 8 days. WT flies infected with voriconazole-exposed R. oryzae 557969 had a significantly lower 8-day survival rate (35%; hazard ratio associated with voriconazole exposure, 1.9; 95% confidence interval [CI], 1.4 -3.6; P Ͻ .001, by the log-rank test) (figure 2A). Tl Ϫ/Ϫ flies were more susceptible to infection with R. oryzae 557969 than were WT flies. The 8-day survival rate among Tl Ϫ/Ϫ flies infected with R. oryzae 557969 was 46%; the survival rate at 8 days among Tl Ϫ/Ϫ flies infected with strains previously exposed to voriconazole was 18% (hazard ratio, 1.7; 95% CI, 1.4 -3.6; P Ͻ .001) (figure 2B).
To determine whether the effect of voriconazole preexposure on Zygomycetes virulence was specific to the R. oryzae 557969 strain, we repeated the experiments described above, using 2 additional Zygomycetes strains: R. oryzae 518749 and M. circinelloides 488128. R. oryzae 518749 demonstrated greater virulence among WT and Tl Ϫ/Ϫ flies than did R. oryzae 557969; the 8-day survival rates among WT and Tl Ϫ/Ϫ flies infected with a R. oryzae 518749 strain that was not exposed to voriconazole were 36% and 19%, respectively. Infection with R. oryzae 518749 preexposed to voriconazole was associated with lower 8-day survival rates among WT flies (20%; hazard ratio, 1.3; 95% CI, 1.03-2.2; P ϭ .03) (figure 2C) and Tl Ϫ/Ϫ flies (5%; hazard ratio, 1.5; 95% CI, 1.4 -3.8; P Ͻ .001) ( figure  2D ). (A and B ) , R. oryzae 518748 (C and D ), and Mucor circinelloides 488128 (E and F ), following exposure to VRC. Each survival curve represents pooled data from 3 independent experiments performed at different times. P values were determined using the log-rank test.
We observed a similar pattern of reduced survival rates associated with preexposure to voriconazole among WT and Tl Ϫ/Ϫ flies infected with M. circinelloides 488128. Specifically, the 8-day survival rates among WT flies infected with voriconazolenonexposed and voriconazole-exposed M. circinelloides 488128 were 53% and 25%, respectively (hazard ratio, 1.9; 95% CI, 1.5-3.4; P Ͻ .001) (figure 2E), and 8-day survival rates among Tl Ϫ/Ϫ flies infected with voriconazole-nonexposed and voriconazole- 4 spores/mL; B ) of VRC-exposed or -nonexposed R. oryzae 557969. Each survival curve represents pooled data from 3 independent experiments performed at different times. P values were determined using the log-rank test. C and D, Corresponding fungal burdens in mouse lungs infected with a high inoculum (C) or a low inoculum (D) of VRC-exposed or -nonexposed R. oryzae 557969. P values were determined using the nonparametric Mann-Whitney U test. Horizontal lines represent medians. SE, spore equivalents. E, Histopathological sections of lungs obtained from mice infected with VRC-exposed or -nonexposed R. oryzae 557969. The sections were stained with hematoxylin-eosin (original magnification, ϫ100 [large panels] or ϫ400 [insets] ). Preexposure of R. oryzae 557969 to VRC was associated with infiltration of pulmonary tissue by polymorphonuclear leukocytes, pronounced angioinvasion, and intravascular hyphal proliferation (black arrows), features that were mild or absent in the lungs of mice infected with VRC-nonexposed R. oryzae.
exposed M. circinelloides 488128 were 46% and 9%, respectively (hazard ratio, 2.6; 95% CI, 2.5-6.1; P Ͻ .001) ( figure 2F) .
Virulence of R. oryzae 557969 preexposed to voriconazole returned to baseline following serial passages on drug-free culture plates. We found that, among WT flies, R. oryzae 557969 that had been exposed to voriconazole and subsequently passaged 4 times on drug-free YAG plates displayed virulence similar to that of R. oryzae 557969 that had not been exposed to voriconazole (8-day survival rates, 38% and 41%, respectively; P ϭ .6).
Exposure of R. oryzae 557969 to a different triazole (itraconazole), a polyene (amphotericin B), or an echinocandin (caspofungin) did not affect its virulence in the fly model of zygomycosis. The survival rates among WT and Tl Ϫ/Ϫ flies infected with R. oryzae 557969 preexposed to itraconazole, amphotericin B, or caspofungin were virtually identical to those among flies infected with R. oryzae 557969 that was not exposed to these drugs. Specifically, the 8-day survival rates among WT flies infected with drug-exposed and drug-nonexposed R. oryzae 557969 were 58% and 54%, respectively, for itraconazole (P ϭ .6); 53% and 55%, respectively, for caspofungin (P ϭ .8); and 51% and 55%, respectively, for amphotericin B (P ϭ .7). Likewise, the survival rate among Tl Ϫ/Ϫ flies infected with itraconazole-exposed R. oryzae 557969 was similar to that among Tl Ϫ/Ϫ flies infected with itraconazole-nonexposed R. oryzae 557969 (P ϭ .8).
Exposure of an A. fumigatus strain to voriconazole did not affect its virulence in Tl ؊/؊ flies. A. fumigatus 293 was virulent in Tl Ϫ/Ϫ flies but not in WT flies [11] . Preexposure of this isolate to a subinhibitory concentration of voriconazole had no effect on its virulence in Tl Ϫ/Ϫ flies. Specifically, 8-day survival rates among Tl Ϫ/Ϫ flies infected with voriconazole-exposed A. fumigatus 293 and voriconazole-nonexposed A. fumigatus 293 were 43% and 44%, respectively (P ϭ .9).
Preexposure of R. oryzae 557969 to voriconazole increased its virulence in a murine model of zygomycosis. To determine whether our observations were confined to flies, we studied the effect of voriconazole exposure on R. oryzae virulence in immunosuppressed mice. We found that cortisone acetate-treated mice were susceptible to infection with both high (10 6 spores/mL) and low (5 ϫ 10 4 spores/mL) inocula of R. oryzae 557969 spores. For both inocula, voriconazoleexposed R. oryzae 557969 was associated with significantly decreased mouse survival rates, compared with voriconazolenonexposed R. oryzae 557969. The 10-day survival rate among mice in the high-inoculum group was 33% for those infected with voriconazole-nonexposed R. oryzae 557969, compared with 7% for those infected with R. oryzae 557969 preexposed to voriconazole (hazard ratio, 1.9; 95% CI, 1.2-4.4; P Ͻ .009) (figure 3A) . Similarly, infection with the low inoculum was associated with a 10-day survival rate of 57% for mice infected with voriconazole-nonexposed R. oryzae 557969, compared with 14% for mice infected with R. oryzae 557969 preexposed to voriconazole (hazard ratio, 2.8; 95% CI, 1.6 -6.8; P Ͻ .001) ( figure  3B ). These results were highly reproducible in 3 repeated experiments. The median fungal burden, measured by qPCR and expressed as spore equivalents, was significantly higher in the lungs of mice infected with R. oryzae 557969 preexposed to voriconazole, compared with the lungs of mice infected with voriconazole-nonexposed R. oryzae 557969, at the high inoculum (2-log difference; P ϭ .002) ( figure 3C ) and the low inoculum (1-log difference; P ϭ .006) ( figure 3D) .
Histopathological examination at an early time point (on day 4) during the course of infection (inoculum, 5 ϫ 10 4 spores/ mL) revealed significant differences between the lungs of mice infected with R. oryzae 557969 preexposed to voriconazole and those of mice infected with voriconazole-nonexposed R. oryzae. Voriconazole preexposure was associated with intense infiltration of pulmonary parenchyma by polymorphonuclear leukocytes, extensive angioinvasion, and intravascular hyphal proliferation. In contrast, lungs infected with nonexposed R. oryzae 557969 exhibited a milder inflammatory response, less frequent angioinvasion, and a lack of intravascular hyphal proliferation ( figure 3E ).
Voriconazole-exposed R. oryzae 557969 induced the expression of genes that encode proinflammatory mediators in the mouse lung. Microarray analysis of 1076 inflammationassociated genes revealed 106 genes with a difference in expression of Ͼ2-fold between mouse lungs infected with R. oryzae 557969 preexposed to voriconazole and those infected with voriconazolenonexposed R. oryzae 557969. The difference in expression of 72 of these genes was statistically significant (P Ͻ .05); 71 of these genes were overexpressed in the lungs of mice infected with voriconazole-exposed R. oryzae 557969 (table 1 and figure 4 , which appear only in the electronic edition of the Journal). These included genes encoding for growth factors, heat-shock proteins, proinflammatory cytokines and their receptors, intercellular adhesion molecules, extracellular matrix proteins, and mediators of angiogenesis (table 1) . In addition, genes encoding components of the mitogen-activated protein kinase signaling pathway (i.e., guanine nucleotide exchange factor and c-Jun)
The figure is available in its entirety in the online edition of the Journal of Infectious Diseases. and the phosphatidylinositol signaling pathway (i.e., Jak1 and phosphatidylinositol 3 kinase) were significantly overexpressed.
DISCUSSION
Although previously considered an uncommon infection, zygomycosis has recently emerged as the second most common opportunistic mycosis after aspergillosis among patients with hematologic malignancies and recipients of hematopoietic stem cell transplants [5] . Several non-mutually exclusive factors may explain the increase in the zygomycosis incidence among patients with cancer [9] . Recent studies have attributed this trend to the use of voriconazole in prophylactic, empirical, or preemptive therapy of fungal infections [2, 4, 5] . Widespread use of voriconazole may create selective pressure favoring the emergence of drug-resistant organisms, such as Zygomycetes.
In the present study, exposure to voriconazole induced a hypervirulent phenotype in 3 different clinical Zygomycetes strains that were used to infect WT and Tl Ϫ/Ϫ D. melanogaster flies. This observation was consistent for 2 different Zygomycetes genera (Rhizopus and Mucor) and for strains displaying different virulence characteristics at baseline. Furthermore, we confirmed our findings in fruit flies by examining a murine model of zygomycosis, in which exposure of R. oryzae to voriconazole before infection was associated with decreased survival rates and increased pulmonary fungal burdens. Our findings highlight the predictive value of a high-throughput minihost model in virulence screening experiments [13, 16] . In addition, these findings offer an alternate explanation for the increasing incidence of zygomycosis among immunosuppressed patients receiving voriconazole-based prophylaxis. Importantly, the increase in the virulence of R. oryzae 557969 was specific for voriconazole, as exposure of this strain to itraconazole, caspofungin, and amphotericin B did not affect its virulence in flies. This finding is consistent with results of a recent clinical case-control study, in which voriconazole exposure but not itraconazole exposure was an independent risk factor for zygomycosis [5] . Furthermore, preexposure of A. fumigatus 293 to voriconazole did not alter its virulence in the fly model. Taken together, these findings suggest that a unique interaction between Zygomycetes organisms and voriconazole alters the virulence of these fungi.
Our comparative microarray-based analysis demonstrated differential overexpression of genes encoding for growth factors, growth factor receptors, associated intracellular signals, and extracellular matrix proteins in the lungs of mice infected with R. oryzae 557969 preexposed to voriconazole. These findings imply that infection with voriconazole-exposed R. oryzae 557969 causes extensive tissue injury, which in turn activates a program of tissue repair and angiogenesis. This conclusion is supported by the enhanced angioinvasion and intense inflammatory infiltration seen in histopathological sections of lungs from mice infected with voriconazoleexposed R. oryzae 557969.
The factors that determine the virulence of Zygomycetes organisms remain largely unknown. Therefore, elucidation of the mechanisms responsible for the voriconazole-associated increase in Zygomycetes virulence is an important direction for future research. The voriconazole-associated changes were inherited across successive mitotic generations: exposure of germinating spores to voriconazole resulted in increased virulence in the next generations of asexual spores. However, the hypervirulent phenotype was lost when exposure to voriconazole was terminated, suggesting an unstable epigenetic modification rather than a genetic change. Assessment of the sporulation rate, growth rate (measured using an XTT colorimetric assay) [17] , and phagocytosis (assessed in Drosophila S2 phagocytic cells) [18] did not reveal any differences between voriconazoleexposed and voriconazole-nonexposed R. oryzae strains (data not shown).
Although the mechanism of increased pathogenicity in voriconazole-exposed Zygomycetes organisms is unknown, some fascinating hypotheses can be entertained. One is that upregulation of a specific efflux pump by voriconazole leads to a fitness gain in Zygomycetes organisms. As described in fluconazoleexposed Candida albicans [19] , up-regulation of an efflux pump in Zygomycetes species could be associated with secretion of virulence factors such as proteases or iron-scavenging siderophores. Alternatively, in view of the plasticity of the ergosterol biosynthetic pathway, it is possible that voriconazole, a weak inhibitor of P-450 demethylase in Zygomycetes organisms, results in the accumulation of alternative nonergosterol sterols in the fungal cell membrane. Such changes in the sterol composition could result in increased adherence to endothelial surfaces or the extracellular matrix. Fortunately, because horizontal transmission of resistance is not operative in Zygomycetes species, expansion of a hypervirulent clone is unlikely once voriconazole pressure is removed.
A potential limitation of our study was the use of a single mode of immunosuppression (i.e., corticosteroid-based treatment) in the murine model to assess voriconazole-associated changes in R. oryzae 557969 virulence. Whether our observations can be generalized to hosts with other types of immune deficits, such as neutropenia induced by exposure to myelosuppressive drugs, remains to be determined.
In conclusion, we found that exposure of Zygomycetes strains to voriconazole increased the virulence of these isolates in 2 phylogenetically disparate models of zygomycosis. Given the increasing incidence and poor outcome of this opportunistic mycosis [1, 2, 9] , the mechanisms underlying the modulation of Zygomycetes virulence by voriconazole should be explored further. Table 1 . Genes significantly overexpressed (>2-fold) in lungs of mice infected with Rhizopus oryzae 557969 isolates that were preexposed to voriconazole, relative to lungs of mice infected with nonpreexposed R. oryzae 557969. 
